🇺🇸 BMS-986374 in United States

Name: Drug Landscape Pharmaceutical Database
Creator: Drug Landscape
Published: 2026-01-01
License: https://creativecommons.org/licenses/by/4.0/

BMS-986374 (BMS-986374) regulatory status in United States.

Marketing authorisation

FDA

Application: ANDA219236
Marketing authorisation holder: SYNTHON BV
Local brand name: OZANIMOD
Indication: CAPSULE
Status: approved

Read official source →

Other Oncology approved in United States

Frequently asked questions

Is BMS-986374 approved in United States?

Yes. FDA has authorised it.

Who is the marketing authorisation holder for BMS-986374 in United States?

SYNTHON BV holds the US marketing authorisation.